[04/22/2011] FDA has updated the Tysabri (natalizumab) Prescribing Information to give new information about the size of the risk of progressive multifocal leukoencephalopathy (PML), a rare […]
FDA Drug Safety Communication: Risk of Oral Clefts in Children Born to Mothers Taking Topamax (topiramate) The U.S. Food and Drug Administration (FDA) is informing the […]
Children born with cardiac and other congenital birth defects have potentially been linked to use of the SSRI class of antidepressant drugs, including Lexapro (Generic: escitalopram). […]
Children born with cardiac and other congenital birth defects have potentially been linked to use of the SSRI class of antidepressant drugs, including Celexa (Generic: citalopram). […]
Children born with cardiac and other congenital birth defects have possibly been linked to use of the anti-depressant drug bupropion (Aplenzin, Wellbutrin, Wellbutrin SR, Wellbutrin XL, […]
Children born with a heart defect, lung defect or other congenital birth defects have possibly been linked to use of the antidepressant drug Zoloft. Research suggests […]
Morristown, NJ – Further to its previously announced voluntary recall of 18 lots of Fentanyl Transdermal System 25 mcg/hour C-II patches, Actavis is encouraging consumers to […]
FDA Adverse Reaction Cold Therapy System FDA: Adverse Reaction Model Number 10B Event Date 11/02/2005 Event Type Injury Patient Outcome Required Intervention; Disability Event Description “Ebice […]
Inspections, Compliance, Enforcement, and Criminal Investigations Depuy Orthopaedics, Inc. 8/19/10 Department of Health and Human Services Public Health ServiceFood and Drug Administration 10903 New Hampshire Avenue […]